MILDECA takes stock of CBD legislation
Following the Kanavape verdict before the Court of Justice of the European Union, which, in a nutshell.., makes France's alleged ban on cannabidiol illegal, the MILDECA, standard-bearer of the «Say no to CBD» campaign, has modified his update on CBD legislation.
As a reminder, the initial text mentioned :
«Thus, certain varieties of cannabis or hemp, devoid of narcotic properties, may be used for industrial and commercial purposes under three cumulative conditions:
- authorized hemp varieties are listed ;
- only seeds and fibers may be used. The use of flowers is prohibited; ;
- the plant must have a THC content of less than 0.2%».»
The second point above was largely invalidated by the CJEU, who noted that CBD is legal even though it «is extracted from the Cannabis sativa [hemp] plant in its entirety and not just from its fibers and seeds».
MILDECA has also removed the reference to the ban on CBD flowers and the presence of THC in the finished product. of its new «A »legislative update".
The French organization, however, remains unchanged in its approach to the subject, stating that «the authorities are already reiterating their warnings about the potentially harmful effects of the as yet little-known CBD molecule. They also point out the health risks associated with Δ-9-tetrahydrocannabinol (THC), a molecule classified as a narcotic, which hemp products are likely to contain».
In 2018, the WHO recommended not classifying CBD as a controlled substance, all such as hemp extracts with -0.2% THC in 2019. Maybe MILDECA still hasn't got the Telex...
For the record, here is the MILDECA's previous position, as we wrote in June 2018, was «scientifically backed and complied with European legislation» (no).
-
Cannabis in Europe4 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Business4 weeks ago
The British medical cannabis market is expected to exceed 140,000 patients by 2026
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange



You must be logged in to post a comment Login